6don MSN
Apple stock falls on analyst downgrade: Gene Munster disagrees – 'I think shares are undervalued'
Apple Inc AAPL shares are falling Monday on an analyst downgrade and concerns about the company’s iPhone supply chain. A ...
It has also aggressively invested in gene editing, including its 2025 acquisition of cardiovascular disease gene-editing ...
The next six months may be decisive for the biotech.
The first half of 2022 was marred by a decline in stocks across all industries with the rise in inflation driving the cost of production as well as the cost of funds needed for operations following ...
Regeneron will make its newly approved gene therapy Otarmeni for a rare, genetic form of hearing loss available for free in the U.S. The company hasn't decided how it will price the therapy overseas, ...
JP Morgan's Cory Kasimov is making bullish bets on these two gene therapy stocks. This is an area with the potential to completely transform the healthcare landscape. It involves making changes to DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results